Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
352 Views
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
424 Views
More Elements of China's Healthcare Reform Beginning to Take Shape
Over the last 90 days, the State Council has announced several new policies related to healthcare reform. In addition, a investment vehicle has...
330 Views
Shanghai Pharmaceuticals (2607 HK) - Recent surge in share price makes us wary - Avoid the deal
Temasek plans to sell US$80m dollars worth of Shanghai Pharmaceutical shares, or about half of its current holding. We would avoid the deal...
368 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
349 Views